Vilya (@vilyatx.bsky.social)

Excited to announce Vilya’s exclusive license for RFpeptides, a groundbreaking RFdiffusion-based model for macrocyclic peptide design from the UW Institute for Protein Design and School of Pharmacy! RFpeptides enable de novo design of potent, selective macrocycles to target undruggable proteins.

loading . . .

Vilya Announces Exclusive License Agreement of RFdiffusion-based Generative Model from the University of Washington for the Design of Macrocyclic Peptides – License of proprietary RFdiffusion-based model, RFpeptides, provides Vilya with another powerful structure prediction framework for rapid and unique... https://www.globenewswire.com/news-release/2024/11/21/2985270/0/en/Vilya-Announces-Exclusive-License-Agreement-of-RFdiffusion-based-Generative-Model-from-the-University-of-Washington-for-the-Design-of-Macrocyclic-Peptides.html